Company intelligence / Profile preview
Insilico Medicine
Boston, Massachusetts, United Statesinsilico.com ↗
- Ownership
- Public · 3696.HK
- Employees
- ~200
- Development stage
- Other
01
Overview
Insilico Medicine has advanced its lead AI-discovered small molecule drug candidate Rentosertib for idiopathic pulmonary fibrosis from target identification to Phase II trials in under three years. The company has demonstrated rapid timelines for asset development using its generative AI platform. Its lead program showed improvements in lung function among IPF patients with a favorable safety profile in a placebo-controlled phase 2a trial. Six pipelines have reached the clinical stage; over 30 assets are in the portfolio with at least nine IND approvals since 2021.
- Therapeutic areas
- OncologyPulmonologyNephrology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
33 assets32 more assets in the full pipeline.
03
Partnerships
WuXi AppTecCollaborations/papers with Novartis and Johnson & JohnsonMultiple validation pilots with leading pharma corporationsCollaboration with Inimmune on immunotherapy drug discovery
04
Financials
- Market cap
- $2.8B
- Enterprise value
- $2.8B
Beyond the preview
Go deeper on Insilico Medicine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Insilico Medicine.